Press Releases

GlobeNewswire, Inc.

CALGARY, Alberta, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Petrus Resources Ltd. (“Petrus” or the “Company”) (TSX: PRQ) is pleased to report financial and operating results as at and for the three and six months ended June 30, 2026. Q2 2026 HIGHLIGHTS:...

GlobeNewswire, Inc.

MONTRÉAL, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Saputo Inc. (TSX: SAP) (we, Saputo or the Company) reported today its financial results for the first quarter of fiscal 2027, which ended on June 30, 2026. All amounts in this news release are in...

GlobeNewswire, Inc.

ISTANBUL, Aug. 06, 2026 (GLOBE NEWSWIRE) -- D-MARKET Electronic Services & Trading (d/b/a “Hepsiburada”) (NASDAQ: HEPS), a leading Turkish e-commerce platform (referred to herein as “Hepsiburada” or the “Company”), today announces its unaudited...

GlobeNewswire, Inc.

NOT FOR DISTRIBUTION IN THE UNITED STATES. FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAW CALGARY, Alberta, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Alaris Equity Partners Income Trust (together, as...

GlobeNewswire, Inc.

Net sales of $1.485 billion, increased 38.0% from the year-ago quarter and up 13.2% sequentially.

GlobeNewswire, Inc.

CAMPBELL, Calif., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Arteris, Inc. (Nasdaq: AIP), a leading provider of semiconductor technology for accelerating innovation in the AI era, today announced financial results for the second quarter ended June 30, 2026...

GlobeNewswire, Inc.

LONG BEACH, Calif., Aug. 06, 2026 (GLOBE NEWSWIRE) -- SkinHealth Systems Inc. (NASDAQ: SKIN) (“SkinHealth Systems” or the "Company"), home to flagship brand Hydrafacial, today announced financial results for the second quarter ended June 30, 2026...

GlobeNewswire, Inc.

Second quarter revenue of $1.1 billion, up 5% year-over-year and when adjusted for foreign exchange* Cloud Infrastructure Services revenue of $99 million, up 39% year-over-year and when adjusted for foreign exchange* Security revenue of $604...

GlobeNewswire, Inc.

– Operating expenses decline 16%, helping drive a 39% improvement in net loss – – Approximately $3.1 million of TULSA revenue recognition shifts into early Q3 due to shipment timing – – Strong clinical, commercial and reimbursement momentum...

GlobeNewswire, Inc.

-- Profitability: Delivered better-than-expected operating results driven by continued tight management of operating expenses -- -- Partnerships: Announced new strategic partnerships with NVIDIA and Dassault Systemes SIMULIA, and deepened...

GlobeNewswire, Inc.

Enrollment completed in TX45 APEX Phase 2 clinical trial in patients with pulmonary hypertension associated with heart failure with preserved ejection fraction (“PH-HFpEF”) with topline results anticipated in early Q1 2027 TX45 APEX Phase 2...

GlobeNewswire, Inc.

DULUTH, Ga., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Fox Factory Holding Corp. (NASDAQ: FOXF) (“FOX” or the “Company”), a premium brand and a global leader in the design, engineering and manufacturing of performance-defining products and systems for...

GlobeNewswire, Inc.

– Company reports record demand for YCANTH® as dispensed applicator units grew to 19,626 in Q2 2026, up 28.3% over the previous quarter and 46.1% year-over-year – – Topline data from global Phase 3 program studying common warts currently expected...

GlobeNewswire, Inc.

Gross margin expanded to 38.9%, up more than 2,200 basis points year-over-year Service revenues grew to $11.5 million, representing 53% of total revenues Operating expenses reduced 57% year-over-year to $14.7 million Adjusted EBITDA loss improved...

GlobeNewswire, Inc.

Quincy, MA, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Stran & Company, Inc. ("Stran" or the "Company") (NASDAQ: SWAG) (NASDAQ: SWAGW), a leading outsourced marketing solutions provider that leverages its promotional products and loyalty incentive...

GlobeNewswire, Inc.

Proposed combination with Clywedog Therapeutics Inc. (“Clywedog”) progressing towards closing Completed enrollment of 42 planned subjects in the Phase 1 AVALON trial evaluating VTP-1000 in patients with celiac disease; topline data from multiple...

GlobeNewswire, Inc.

HERZLIYA, Israel, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Nayax Ltd. (Nasdaq: NYAX; TASE: NYAX), a global commerce enablement and payments platform designed to help customers scale their business by simplifying payments and maximizing loyalty, today...

GlobeNewswire, Inc.

Immunocore reports second quarter financial results and provides a business update KIMMTRAK® (tebentafusp-tebn) net revenues of $115.9 million in Q2 2026, growing by 18% year-over-year Enrollment in Phase 3 TEBE-AM trial for previously treated...

GlobeNewswire, Inc.

Enrollment complete in Phase 3 SONATA-HCM study; top-line data expected Q1 2027 NDA resubmission activities for ZYNQUISTA® in type 1 diabetes nearing completion Phase 1 clinical development of LX9851 ongoing by Novo Nordisk Conference call and...

GlobeNewswire, Inc.

Conference Call and Webcast Today at 8:30 a.m. ET Received U.S. Food and Drug Administration (FDA) clearance to initiate OCU410 Phase 3 trial for geographic atrophy (GA), secondary to dry age-related macular degeneration (AMD); on track to...